(VOVWORLD) -A fourth dose of the Pfizer/BioNTech vaccine lowered rates of COVID-19 among the elderly but the protection against infection appeared short-lived, Reuters quoted findings of a...
(VOVWORLD) - Prime Minister Pham Minh Chinh has requested the Ministry of Health to direct centrally-run cities and provinces to speed up the vaccination of the third dose of COVID...
(VOVWORLD) - AstraZeneca said on Thursday preliminary data from a trial it conducted on its COVID-19 shot, Vaxzevria, showed it generated a higher antibody response against the Omicron variant and others, including Beta...
(VOVWORLD) - As many as 21 million Indonesians will get a third dose of COVID-19 vaccine as an antibody booster, Health Minister Budi Gunadi Sadikin said Monday
(VOVWORLD) - A three-dose course of AstraZeneca's COVID-19 vaccine is effective against the rapidly-spreading Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an...
(VOVWORLD) - Israeli researchers said on Saturday they found that a three-shot course of the Pfizer/BioNTech COVID-19 vaccine provided significant protection against the new Omicron variant
(VOVWORLD) - COVID-19 vaccines made by Pfizer and Moderna that use mRNA technology provide the biggest boost to antibody levels when given 10-12 weeks after the second dose, a...
(VOVWORLD) - According to worldometers.info, as of Saturday, the world recorded nearly 250 million COVID-19 infections. More than 5 million people have died from the disease
(VOVWORLD) - Australia’s Therapeutic Goods Administration (TGA) on Wednesday provisionally approved a booster dose of the Pfizer/BioNTech COVID-19 vaccine for individuals 18 years and older
(VOVWORLD) - A booster dose of the COVID-19 vaccine developed by Pfizer and German partner BioNTech restored efficacy to 95.6% against the virus, including the Delta variant, data released...
(VOVWORLD) -Pfizer plans to ask US regulators to authorize a booster dose of its COVID-19 vaccine within the next month, the drugmaker's top scientist said on Thursday, based...